Eric Zimmerman - McDermott+Consulting

Overview


Eric is a recognized Medicare law and policy authority and registered lobbyist who helps clients navigate federal legislative and regulatory processes related to Medicare coverage, coding, reimbursement and compliance.

Eric represents some of the country’s largest and most renowned health service providers, product manufacturers and trade associations before Congress, the US Department of Health and Human Services, the Centers for Medicare and Medicaid Services and other federal agencies. He was recently recognized by Business Insider as one of 34 DC Healthcare power players and featured on The Hill’s Top Lobbyist list for 2021.

Education


  • George Mason University School of Law, J.D., 1997
  • George Washington University, M.B.A., 1993
  • Emory University, B.A., 1989

Representative Experience


  • Lead Washington representative for Trinity Health, the nation’s second largest Catholic health system.
  • Lead Washington representative for the Medicare-dependent Rural Hospital Coalition, a collaboration of 30 hospitals with MDH status dedicated to protecting and enhancing the benefits attendant that status.
  • Lead Washington representative for the Rural Referral Center/Sole Community Hospital Coalition, a collaboration of 80 hospitals with RRC or SCH status dedicated to protecting and enhancing the benefits attendant those designations.
  • Lead Washington representative for the Diabetes Access to Care Coalition, a lobbying collaboration among the major global manufacturers of diabetes testing equipment and supplies.
  • Washington representative of the Coalition for 21st Century Medicine, a collaborative effort among developers of and stakeholders interested in advanced laboratory diagnostics.

Insights and In the News


CMS Releases FY 2025 IPPS Proposed Update

McDermott+Consulting Announces Promotions

Health Policy Outlook for 2024

CMS Releases CY 2024 Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems ...

CMS Finalizes Remedy for 340B-Acquired Drugs Purchased in CYs 2018–2022

McDermott+Consulting Expands Market Access Capabilities with New Vice President

CMS Releases FY 2024 IPPS Final Rule

CMS Releases CY 2024 Outpatient Prospective Payment System and Ambulatory Surgical Center Payment ...

CMS Releases Proposed Remedy for 340B-Acquired Drugs Purchased in Cost Years 2018–2022

Regs & Eggs Blog Moves to McDermott+Consulting, Providing Weekly Updates on Federal ...

McDermott+Consulting Expands Health Policy and Lobbying Capabilities with Two Additions

Site Neutral Payment: Top 10 Services Likely to Be Impacted By Proposed Legislation

CMS Releases FY 2024 IPPS Proposed Update

2023 Health Policy Outlook

Consolidated Appropriations Act, 2023: Health Provisions

Way Too Early Preview: What the Midterm Election Results Might Mean for ...

Recorded Webinar—2022 Midterm Election Results: What to Watch in Health Policy

CMS Releases CY 2023 Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems ...

CMS Releases FY 2023 IPPS Final Rule

CMS Releases CY 2023 Outpatient Prospective Payment System and Ambulatory Surgical Center Payment ...

CMS Releases FY 2023 IPPS Proposed Update

Senior Director Rachel Stauffer Returns to McDermott+Consulting

2022 Health Policy Outlook

HEALTH CARE BRIEFING: At-Home Covid Test Makers Want More Access

Key Takeaways from the 2nd Part of FY 2022 IPPS Final Rule

McDermottPlus Expands Health Policy and Data Analytics Capabilities with Three Distinguished Additions

Interim Final Rule with comment (IFR) to Surprise Billing; Part II

McDermott+Consulting Expands Advocacy and Policy Strength with Two Director Additions

CMS Releases FY 2022 IPPS Final Rule

Health Policy Breakroom - Ep 75 No Surprises Billing Act 1 day ago1 day ...

Requirements Related to Surprise Billing; Part I: Policy Update

McDermott+Consulting Continues Rapid Growth with Addition of Health Policy Expert Debbie ...

President’s Fiscal Year 2022 Budget: What You Need to Know

McDermott+Consulting Grows with Addition of Two Seasoned Data Analytics Professionals

American Rescue Plan Act of 2021: Key Healthcare Provisions

The First 100 Days: Biden's Healthcare Outlook

Summary of Key Health Provisions in the Consolidated Appropriations Act, 2021

Drug Pricing – Trump Administration Announces Most-Favored Nation Drug Pricing Model

A New President Signals a New Focus for Federal Health Policy

‘Doc Fix’ Bill Elicits Grumbling, But Swift Passage Likely

Show More

Eric Zimmerman

Insights & Events / Media

No results using the selected filter(s)